According to the literature, the content of FIN1, TUBA4A, and MVP proteins, identified by us as universal EV markers, up-regulated in the blood plasma of patients with NSCLC compared to healthy donors [54]. This evidence concerns the gene MVP and non-small cell lung carcinoma.